Eli M. Wallace

3.5k total citations · 1 hit paper
19 papers, 1.7k citations indexed

About

Eli M. Wallace is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Eli M. Wallace has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Eli M. Wallace's work include Cancer, Hypoxia, and Metabolism (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Eli M. Wallace is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Eli M. Wallace collaborates with scholars based in United States, Germany and United Kingdom. Eli M. Wallace's co-authors include James A. Marshall, John A. Josey, Mark A. Wolf, Xinlin Du, Paul S. Coan, James P. Rizzi, Keshi Wang, Wenhua Gao, Richard K. Bruick and Sabina Signoretti and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Journal of Medicinal Chemistry.

In The Last Decade

Eli M. Wallace

19 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models

2016 336 citations Hyejin Cho, Xinlin Du et al. Nature profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Eli M. Wallace	729	624	576	347	188	19	1.7k
M.R.L. Stratford	765 1.0×	565 0.9×	273 0.5×	284 0.8×	318 1.7×	57	1.7k
Vivien E. Prise	1.1k 1.4×	576 0.9×	313 0.5×	168 0.5×	401 2.1×	34	1.9k
James P. Rizzi	894 1.2×	386 0.6×	249 0.4×	149 0.4×	128 0.7×	20	1.3k
Elaine S. E. Stokes	999 1.4×	276 0.4×	367 0.6×	353 1.0×	609 3.2×	28	1.7k
Bronwyn G. Siim	738 1.0×	766 1.2×	245 0.4×	94 0.3×	276 1.5×	23	1.4k
Karine Ilc	1.1k 1.6×	720 1.2×	164 0.3×	104 0.3×	239 1.3×	14	1.6k
Ann M. McNulty	975 1.3×	228 0.4×	151 0.3×	452 1.3×	435 2.3×	33	1.7k
Cinzia Lanzi	1.5k 2.1×	317 0.5×	248 0.4×	249 0.7×	895 4.8×	73	2.4k
Giuliana Cassinelli	1.4k 1.9×	356 0.6×	260 0.5×	425 1.2×	1.0k 5.4×	64	2.5k
Stefan Engst	1.1k 1.5×	257 0.4×	148 0.3×	531 1.5×	688 3.7×	16	2.0k

Countries citing papers authored by Eli M. Wallace

Since Specialization

Citations

This map shows the geographic impact of Eli M. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli M. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli M. Wallace more than expected).

Fields of papers citing papers by Eli M. Wallace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli M. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli M. Wallace. The network helps show where Eli M. Wallace may publish in the future.

Co-authorship network of co-authors of Eli M. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Eli M. Wallace. A scholar is included among the top collaborators of Eli M. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli M. Wallace. Eli M. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Macías, David, Stephen D. Moore, Alexi Crosby, et al.. (2020). Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension. European Respiratory Journal. 57(3). 1902061–1902061. 27 indexed citations

Xu, Rui, Keshi Wang, James P. Rizzi, et al.. (2019). 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma. Journal of Medicinal Chemistry. 62(15). 6876–6893. 156 indexed citations

Hu, Cheng‐Jun, Jens M. Poth, Hui Zhang, et al.. (2019). Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension. European Respiratory Journal. 54(6). 1900378–1900378. 87 indexed citations

Du, Xinlin, Robert Czerwiński, Carlos Huerta, et al.. (2019). Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820. Structure. 27(11). 1625–1633.e3. 130 indexed citations

Hinklin, Ronald J., Brian R. Baer, Steven A. Boyd, et al.. (2019). Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator. Bioorganic & Medicinal Chemistry. 28(1). 115232–115232. 10 indexed citations

Courtney, Kevin D., Jeffrey R. Infante, Elaine T. Lam, et al.. (2017). Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma. Journal of Clinical Oncology. 36(9). 867–874. 296 indexed citations

Cho, Hyejin, Xinlin Du, James P. Rizzi, et al.. (2016). On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models. Nature. 539(7627). 107–111. 336 indexed citations breakdown →

Xu, Rui, James F. Blake, Ian S. Mitchell, et al.. (2011). Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA. Bioorganic & Medicinal Chemistry Letters. 21(8). 2335–2340. 10 indexed citations

Wallace, Eli M., Joseph P. Lyssikatos, James F. Blake, et al.. (2005). Potent and Selective Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors. 1. 4-(4-Bromo-2-fluorophenylamino)-1- methylpyridin-2(1H)-ones. Journal of Medicinal Chemistry. 49(2). 441–444. 34 indexed citations

10.

Lombaert, Stéphane De, Louis Blanchard, Jenny Tan, et al.. (2000). Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting Enzyme-1 with Sustained Duration of Action. Journal of Medicinal Chemistry. 43(3). 488–504. 87 indexed citations

11.

Wallace, Eli M., John Moliterni, Alan D. Neubert, et al.. (1998). Design and Synthesis of Potent, Selective Inhibitors of Endothelin-Converting Enzyme. Journal of Medicinal Chemistry. 41(9). 1513–1523. 44 indexed citations

12.

Lombaert, Stéphane De, Louis Blanchard, Jenny Tan, et al.. (1997). Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11. Bioorganic & Medicinal Chemistry Letters. 7(8). 1059–1064. 26 indexed citations

13.

Marshall, James A., Mark A. Wolf, & Eli M. Wallace. (1997). Synthetic Routes to Allenic Acids and Esters and Their Stereospecific Conversion to Butenolides. The Journal of Organic Chemistry. 62(2). 367–371. 163 indexed citations

14.

Marshall, James A., et al.. (1996). Total Synthesis of the Pseudopterane (−)-Kallolide B, the Enantiomer of Natural (+)-Kallolide B. The Journal of Organic Chemistry. 61(17). 5729–5735. 63 indexed citations

15.

Marshall, James A., Eli M. Wallace, & Paul S. Coan. (1995). Total Synthesis of the Pseudopterane (.+-.)-Kallolide B. The Journal of Organic Chemistry. 60(4). 796–797. 110 indexed citations

16.

Barrett, Anthony G. M., et al.. (1993). The conversion of carboxylic acids into isonitriles via selenium-phenyl selenocarbamates. Journal of the Chemical Society Chemical Communications. 1760–1760. 15 indexed citations

17.

Barrett, Anthony G. M., Toshiyuki Itoh, & Eli M. Wallace. (1993). (η6-Benzene)(η5-ethyltetramethylcyclopentadienyl)rhodium (III) hexafluorophosphate: A reagent for catalytic phenol oxidative coupling. Tetrahedron Letters. 34(14). 2233–2234. 25 indexed citations

18.

Barrett, Anthony G. M., Jason M. Hill, & Eli M. Wallace. (1992). Stereoselective alkene synthesis via (.alpha.-chloroalkyl)(dimethyl)phenylsilanes and .alpha.-(dimethyl)phenylsilyl ketones. The Journal of Organic Chemistry. 57(1). 386–389. 17 indexed citations

19.

Barrett, Anthony G. M., Jason M. Hill, Eli M. Wallace, & John A. Flygare. (1991). Recent Studies on the Peterson Olefination Reaction. Synlett. 1991(11). 764–770. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact